Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

NCT00547482 is registered in ClinicalTrials.gov with MetaCure (USA), Inc. as lead sponsor.

NCT NCT00547482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00547482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study
Lead sponsor
MetaCure (USA), Inc.
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2007
Completion date
November 30, 2009
Enrollment
300 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

overweight, type 2 diabetes mellitus